These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6861880

  • 21. The recording of venous compliance in the conscious dog: a method for the assessment of venoconstrictor agents.
    Müller-Schweinitzer E.
    J Pharmacol Methods; 1984 Aug; 12(1):53-8. PubMed ID: 6536814
    [Abstract] [Full Text] [Related]

  • 22. Effects of dihydroergotamine and sumatriptan on isolated human cerebral and peripheral arteries and veins.
    Nilsson F, Nilsson T, Edvinsson L, Björkman S, Nordström CH.
    Acta Anaesthesiol Scand; 1997 Nov; 41(10):1257-62. PubMed ID: 9422289
    [Abstract] [Full Text] [Related]

  • 23. Influence of dihydrolysergic acid amide on serotonergic and alpha-adrenergic receptors in human blood platelets and femoral veins in vitro.
    Glusa E, Markwardt F.
    Arch Int Pharmacodyn Ther; 1986 Oct; 283(2):303-11. PubMed ID: 3024599
    [Abstract] [Full Text] [Related]

  • 24. Vasoconstrictor effect of midodrine, ST 1059, noradrenaline, etilefrine and dihydroergotamine on isolated human veins.
    Thulesius O, Gjöres JE, Berlin E.
    Eur J Clin Pharmacol; 1979 Oct; 16(6):423-4. PubMed ID: 93544
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing.
    de Marées H, Welzel D, de Marées A, Klotz U, Tiedjen KU, Knaup G.
    Eur J Clin Pharmacol; 1986 Oct; 30(6):685-9. PubMed ID: 3533566
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Importance of inositol (1,4,5)-trisphosphate, intracellular Ca2+ release and myofilament Ca2+ sensitization in 5-hydroxytryptamine-evoked contraction of rabbit mesenteric artery.
    Seager JM, Murphy TV, Garland CJ.
    Br J Pharmacol; 1994 Feb; 111(2):525-32. PubMed ID: 8004397
    [Abstract] [Full Text] [Related]

  • 31. What is known about the action of dihydroergotamine on the vasculature in man?
    Müller-Schweinitzer E.
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):677-82. PubMed ID: 6396240
    [Abstract] [Full Text] [Related]

  • 32. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM, De Vries P, Rabelo G, Centurión D, Sánchez-López A, Saxena P.
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data.
    de Hoon JN, Poppe KA, Thijssen HH, Struijker-Boudier HA, Van Bortel LM.
    Br J Clin Pharmacol; 2001 Jul; 52(1):45-51. PubMed ID: 11453889
    [Abstract] [Full Text] [Related]

  • 36. Regional differences in the responsiveness of isolated arteries from cattle, dog and man.
    Müller-Schweinitzer E, Weidmann H.
    Agents Actions; 1977 Sep; 7(3):383-9. PubMed ID: 596322
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man.
    Aellig WH.
    Eur J Clin Pharmacol; 1984 Sep; 26(2):239-42. PubMed ID: 6547094
    [Abstract] [Full Text] [Related]

  • 39. Paradoxical relaxation of arterial strips induced by vasoconstrictive agents.
    Ohhashi T, Azuma T.
    Blood Vessels; 1980 Sep; 17(1):16-26. PubMed ID: 7357093
    [Abstract] [Full Text] [Related]

  • 40. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
    Jourdan G, Verwaerde P, Pathak A, Tran MA, Montastruc JL, Senard JM.
    Fundam Clin Pharmacol; 2007 Feb; 21(1):45-53. PubMed ID: 17227444
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.